Jim Gallagher

On-Demand Webinar

第 2 部分：Oligonucleotide therapeutic development: Pre-clinical and translational considerations

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

Jim Gallagher2021 年 4 月 21 日

网络研讨会点播

第 1 部分：What are oligonucleotide therapeutics, and how do they work?

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

Jim Gallagher2021 年 4 月 21 日

On-Demand Webinar

Plan to Accelerate Your Time to Drug Submissions

There are common themes driving how quickly you can get from your last database lock…

Jim Gallagher2021 年 4 月 20 日

On-Demand Webinar

将 PBPK 模型应用于儿科药物开发的最佳实践框架

Pediatric PBPK models have broad application in the drug development process and are being used…

Jim Gallagher2021 年 4 月 20 日

Publication

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…

Jim Gallagher2021 年 4 月 8 日

On-Demand Webinar

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…

Jim Gallagher2021 年 4 月 1 日

Article

Legislators: Bring all stakeholders to the table to lower drug costs

BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…

Jim Gallagher2021 年 3 月 30 日

Brochure

利用兼容的数据存储库显著改善生物统计学工作流程

Jim Gallagher2021 年 3 月 25 日

Publication

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

The extent of cross-protection provided by currently licensed bivalent and quadrivalent HPV vaccines versus direct…

Jim Gallagher2021 年 3 月 18 日

Publication

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: 双氯芬酸钠局部用凝胶案例，1％

Jim Gallagher2021 年 3 月 16 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Jim Gallagher

第 2 部分：Oligonucleotide therapeutic development: Pre-clinical and translational considerations

第 1 部分：What are oligonucleotide therapeutics, and how do they work?

Plan to Accelerate Your Time to Drug Submissions

将 PBPK 模型应用于儿科药物开发的最佳实践框架

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

Legislators: Bring all stakeholders to the table to lower drug costs

利用兼容的数据存储库显著改善生物统计学工作流程

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: 双氯芬酸钠局部用凝胶案例，1％

订阅时事通讯

快捷链接

解决方案

联系我们